Gaviscon
Unknown brand
Processing
4
Ultra-processed
Group 4 of 4 on the NOVA scale
Additives listed
1
0 we grade moderate or higher
Counted from the label, not by quantity
Nutrients
–
Nothing above the low band
Or no figures recorded at all
Three separate readings, kept apart on purpose. This is not a score, and none of it says this product is harmful.
Additives (1)
This label lists 1 sweetener.
E951
Aspartame
Artificial sweetener
What it is. An intense sweetener around 200 times sweeter than sugar, used in tiny amounts.
Why it is used. Sweetens diet drinks, sugar free gum and low calorie desserts.
What the evidence says. In 2023 IARC listed it as possibly carcinogenic, its weakest evidence tier. At the same time the expert intake committee JECFA kept the safe daily limit unchanged, noting you would need a very high daily intake to approach it, roughly a dozen or more cans of diet drink a day for an adult. So headline scary, practically low concern for normal use.
Permitted with an acceptable daily intake. People with the condition PKU must avoid it, which is why packs carry a phenylalanine note.
Assessed against IARC, JECFA, EFSA. Full entry for E951
Ingredients
12. Before taking Gaviscon Advance Mint Chewable Do not take Gaviscon Advance Mint Chewable T you are allergic to any of the ingredients listed in This product contains 4.5 mg of aspartame (E951) in each Aspartame is a source of phenylalanine. It may be harmf have phenylketonuria (PKU), a rare genetic disorder in whi phenylalanine builds up because the body cannot reme Please consult your doctor before taking Gavisc Advance Mint Chewable Tablets if you: are on a potassium, sodium or calcium restricted d suffer from heart disease or kidney disease are taking diuretics ('water tablets") for high blood as the salt content of these tablets can affect the a diseases and the effect of diuretics
As printed on the pack, in the producer's own order: ingredients are listed by weight, so what comes first is most of what is in it. E numbers link to their assessment where we have one.